These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11729015)

  • 41. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia.
    Mitte K
    J Affect Disord; 2005 Sep; 88(1):27-45. PubMed ID: 16005982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perceived Parental Bonding, Early Maladaptive Schemas and Outcome in Schema Therapy of Cluster C Personality Problems.
    Hoffart Lunding S; Hoffart A
    Clin Psychol Psychother; 2016; 23(2):107-17. PubMed ID: 25425509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term outcome of panic disorder with agoraphobia treated by exposure.
    Fava GA; Rafanelli C; Grandi S; Conti S; Ruini C; Mangelli L; Belluardo P
    Psychol Med; 2001 Jul; 31(5):891-8. PubMed ID: 11459386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
    Bandelow B; Broocks A; Pekrun G; George A; Meyer T; Pralle L; Bartmann U; Hillmer-Vogel U; Rüther E
    Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia.
    Mavissakalian M; Perel JM
    Am J Psychiatry; 1992 Aug; 149(8):1053-7. PubMed ID: 1636805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific side effects of long-term imipramine management of panic disorder.
    Mavissakalian M; Perel J; Guo S
    J Clin Psychopharmacol; 2002 Apr; 22(2):155-61. PubMed ID: 11910260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Conflict-centered individual therapy or integration of psychotherapy methods. Process of change in client-centered psychotherapy with and without behavioral exposure therapy in agoraphobia with panic disorder].
    Teusch L; Böhme H; Finke J
    Nervenarzt; 2001 Jan; 72(1):31-9. PubMed ID: 11221554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
    Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brief treatment of emergency room patients with panic attacks.
    Swinson RP; Soulios C; Cox BJ; Kuch K
    Am J Psychiatry; 1992 Jul; 149(7):944-6. PubMed ID: 1351703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review.
    Furukawa TA; Watanabe N; Churchill R
    Br J Psychiatry; 2006 Apr; 188():305-12. PubMed ID: 16582055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Duration of imipramine therapy and relapse in panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM
    J Clin Psychopharmacol; 2002 Jun; 22(3):294-9. PubMed ID: 12006900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
    Mavissakalian M; Perel JM
    Arch Gen Psychiatry; 1992 Apr; 49(4):318-23. PubMed ID: 1558466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What is the effect on comorbid personality disorder of brief panic-focused psychotherapy in patients with panic disorder?
    Keefe JR; Milrod BL; Gallop R; Barber JP; Chambless DL
    Depress Anxiety; 2018 Mar; 35(3):239-247. PubMed ID: 29212135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emotion Regulation Strategies in Cognitive Behavioral Therapy for Panic Disorder.
    Strauss AY; Kivity Y; Huppert JD
    Behav Ther; 2019 May; 50(3):659-671. PubMed ID: 31030881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term outcome of panic disorder treatment. A review of the literature.
    Milrod B; Busch F
    J Nerv Ment Dis; 1996 Dec; 184(12):723-30. PubMed ID: 8994455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.
    Barlow DH; Gorman JM; Shear MK; Woods SW
    JAMA; 2000 May; 283(19):2529-36. PubMed ID: 10815116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychotherapy for panic disorder.
    Shear MK
    Psychiatr Q; 1995; 66(4):321-8. PubMed ID: 8584588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brief cognitive therapy for panic disorder: a randomized controlled trial.
    Clark DM; Salkovskis PM; Hackmann A; Wells A; Ludgate J; Gelder M
    J Consult Clin Psychol; 1999 Aug; 67(4):583-9. PubMed ID: 10450630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rate of improvement during cognitive-behavioral group treatment for panic disorder.
    Penava SJ; Otto MW; Maki KM; Pollack MH
    Behav Res Ther; 1998; 36(7-8):665-73. PubMed ID: 9682523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maintenance drug therapy of panic disorder.
    Curtis GC; Massana J; Udina C; Ayuso JL; Cassano GB; Perugi G
    J Psychiatr Res; 1993; 27 Suppl 1():127-42. PubMed ID: 8145175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.